Jeffrey C. Kunins Sells 1,370 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) insider Jeffrey C. Kunins sold 1,370 shares of the stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $639.14, for a total value of $875,621.80. Following the transaction, the insider now owns 125,950 shares in the company, valued at approximately $80,499,683. This trade represents a 1.08 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Axon Enterprise Stock Down 2.1 %

Shares of Axon Enterprise stock opened at $635.76 on Wednesday. The company has a 50 day moving average of $548.26 and a 200 day moving average of $411.38. Axon Enterprise, Inc. has a 52-week low of $241.72 and a 52-week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $48.48 billion, a P/E ratio of 164.28, a P/E/G ratio of 14.19 and a beta of 1.01.

Hedge Funds Weigh In On Axon Enterprise

Large investors have recently made changes to their positions in the stock. Public Sector Pension Investment Board grew its position in shares of Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the period. CIBC Asset Management Inc grew its position in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after acquiring an additional 895 shares during the last quarter. Foundations Investment Advisors LLC bought a new position in shares of Axon Enterprise in the third quarter worth $221,000. Sequoia Financial Advisors LLC increased its position in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after purchasing an additional 81 shares during the period. Finally, Axxcess Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at $814,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on AXON shares. The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $488.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.